Unlock instant, AI-driven research and patent intelligence for your innovation.

Pyrrolidone derivative serving as glucokinase activator as well as preparation method and application of pyrrolidone derivative

A compound, alkyl technology, applied in the field of medicine, can solve problems such as difficulty in achieving blood sugar control goals, weight gain, etc.

Pending Publication Date: 2021-10-12
TIANJIN INSTITUTE OF PHARMA RESEARCH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These drugs have a good therapeutic effect, but there are different degrees of safety problems in long-term treatment, such as: weight gain, gastrointestinal reactions, cardiovascular side effects, hypoglycemia, urinary system infection, etc. It is difficult to achieve the ideal blood sugar control target, so there is an urgent need for diabetes treatment drugs with a new mechanism of action in clinic

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyrrolidone derivative serving as glucokinase activator as well as preparation method and application of pyrrolidone derivative
  • Pyrrolidone derivative serving as glucokinase activator as well as preparation method and application of pyrrolidone derivative
  • Pyrrolidone derivative serving as glucokinase activator as well as preparation method and application of pyrrolidone derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0129] The synthesis of embodiment 1 compound I-1

[0130]

[0131] a.

[0132] A solution of 3-aminopyrazole (1.22g, 14.68mmol) in ethyl acetate (10mL) was heated to 45°C, and then acetic anhydride (1.35g, 13.21mmol) was slowly added dropwise at this temperature. , Keep at this temperature for 6h. The mixture was cooled to 25 °C, ethyl acetate (20 mL) was added, and kept at this temperature for 2 h, then the solution was filtered to obtain insoluble material, and pure product 9-1 (1.80 g, 98%) was obtained: LR-ES-MS m / z calculated value C 5 h 7 N 3 O[M] + 125, measured value [M+H] + 126.

[0133] b.

[0134] A suspension of compound 9-1 (1.65g, 13.19mmol) and 2,4-difluorobenzyl bromide (3.01g, 14.53mmol) in N,N-dimethylformamide (DMF, 50mL) was dissolved in sodium carbonate (3.50 g, 32.98 mmol) was treated, then the mixture was heated to 50 °C and kept at this temperature for 5 h. The mixture was cooled to 25°C, and the insolubles were filtered off. The superna...

Embodiment 2

[0147] The synthesis of embodiment 2 compound I-2

[0148]

[0149] a.

[0150] 3-Acetamidopyrazole (prepared as in Example 1, 1.55 g, 12.40 mmol) and 2-fluoro-4-chlorobenzyl chloride (2.45 g, 13.66 mmol) were dissolved in N,N-dimethylformamide ( The suspension in DMF, 60 mL) was treated with potassium carbonate (4.28 g, 31.00 mmol), then the mixture was heated to 50 °C and maintained at this temperature for 5 h. The mixture was cooled to 25°C, and the insolubles were filtered off. The supernatant was concentrated and purified by column chromatography (0% to 100% ethyl acetate / petroleum ether) to give pure 11-2 (2.26 g, 68%): LR-ES-MS m / z calculated C 12 h 11 ClFN 3 O[M] + 267, measured value [M+H] + 268.

[0151] b.

[0152] Compound 11-2 (2.02g, 7.56mmol) was added to a solution made of sodium hydroxide (0.90g, 22.5mmol) and water (2.67g, 148.18mmol) and ethanol (24mL), then the mixture was heated to reflux , and kept at this temperature for 6h. The mixture was ...

Embodiment 3

[0163] The synthesis of embodiment 3 compound Ⅰ-3

[0164]

[0165] a.

[0166] To a stirred mixture of 2-chlorophenol (1.71 g, 15.26 mmol) and ethyl 2-butynoate (1.43. g, 12.70 mmol) in acetonitrile (15 mL) was added triethylenediamine gradually under nitrogen atmosphere (DABCO, 0.51 g, 4.58 mmol), after the addition was complete, the mixture was stirred at reflux for 10 h. After the completion of the reaction, add water (10mL) and methyl tert-butyl ether (20mL) to the mixture, adjust the pH of the aqueous phase with concentrated hydrochloric acid under stirring 12 h 13 FO 3 [M] + 224, measured value [M+H] + 225.

[0167] b.

[0168] To a stirred mixture of compound 3-3 (1.99 g, 8.88 mmol) dissolved in carbon tetrachloride (25 mL) was added N-bromosuccinimide (NBS, 2.72 g, 15.10 mmol) under nitrogen atmosphere ) and azobisisobutyronitrile (AIBN, 0.22 g, 1.33 mmol). After the addition was complete, the mixture was stirred at reflux for 20 h. The reaction mixture wa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pyrrolidone derivative, and more specifically relates to a compound with a structure represented by a formula (I) or a pharmaceutically acceptable salt thereof, and a preparation method and an application of the compound or the pharmaceutically acceptable salt thereof. These compounds, as well as pharmaceutical compositions comprising them, are useful as glucokinase activators for the treatment of metabolic diseases and disorders. R1, R2, R3, R4, R5, X and A are as described in the specifications of the invention.

Description

technical field [0001] The invention belongs to the technical field of medicine. Specifically, the present invention relates to a class of pyrrolidone derivative compounds and their preparation methods and uses. These compounds and pharmaceutical compositions containing them are useful as glucokinase activators in the treatment of metabolic diseases and disorders. Background technique [0002] Diabetes is a major public health problem due to its increasing prevalence and associated health risks. The disorder is characterized by metabolic defects in the production and utilization of carbohydrates, resulting in an inability to maintain proper blood sugar levels. According to the etiology and clinical manifestations, diabetes is mainly divided into four types: insulin-dependent (type I), non-insulin-dependent (type II), malnutrition-related and secondary diabetes. Among them, patients with type Ⅱ diabetes (T2D) account for more than 90% of the total number of people with dia...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D403/12C07D401/14A61P3/00A61P3/10A61K31/4155A61K31/4439A61K31/4709
CPCC07D403/12C07D403/14A61P3/00A61P3/10
Inventor 刘长鹰刘巍刘钰强商倩姚晨辉陈会慧李兴伟
Owner TIANJIN INSTITUTE OF PHARMA RESEARCH